A significant reduction in the diagnosis of melanoma during the COVID-19 lockdown in a third-level center in the Northern Italy

Dermatol Ther. 2020 Nov;33(6):e14074. doi: 10.1111/dth.14074. Epub 2020 Aug 13.

Authors

Stefania Barruscotti^{1

2}, Chiara Giorgini¹, Valeria Brazzelli¹, Camilla Vassallo¹, Andrea Michelerio¹, Catherine Klersy³, Silvia Chiellino⁴, Carlo Francesco Tomasini¹

Affiliations

¹ Department of Clinical-Surgical, Diagnostic and Pediatric Science, Institute of Dermatology, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy.
² PhD Experimental Medicine, University of Pavia, Pavia, Italy.
³ Clinical Epidemiology and Biometry Unit, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy.
⁴ Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

PMID: 32713046
DOI: 10.1111/dth.14074

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
COVID-19 / epidemiology
COVID-19 / prevention & control*
Female
Humans
Italy / epidemiology
Male
Melanoma / diagnosis
Melanoma / epidemiology*
Middle Aged
Retrospective Studies
SARS-CoV-2*
Skin Neoplasms / epidemiology*
Skin Neoplasms / surgery